Sensient Yeast Technologies Double Dairy Culture Yields, Optimise Fermentation Efficiency
Sensient BioNutrients' new Amberferm Grow 288 and 289 yeast-based technologies reportedly double dairy culture yields, offering manufacturers enhanced production efficiency without capital expenditure. This innovation addresses rising demand for fermented dairy, presenting opportunities for improved ingredient supply and cost control.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Sensient Flavors & Extracts has introduced Amberferm Grow 288 and 289, advanced yeast-based fermentation technologies engineered to significantly enhance dairy culture production. These solutions are specifically designed to enable dairy culture manufacturers to boost output and improve culture performance without requiring additional capital investment in new equipment or facilities. The core benefit stems from their ability to maximise fermentation efficiency, a critical factor in meeting the escalating global demand for cultured dairy products and their derivatives, which include ingredients used in supplements.
According to Sensient, Amberferm Grow 288 and 289 are compatible with a broad spectrum of dairy culture strains. Early applications indicate a substantial improvement in fermentation yield and culture activity. Crucially, Sensient states that in some applications, these technologies have doubled the yield when compared to industry-standard fermentation nutrients. This yield increase allows manufacturers to produce more culture using their current fermentation capacity, directly impacting the availability and pricing of fermented ingredients for the supplement sector.
The benefits extend beyond raw yield. Sensient BioNutrients highlights improvements in packed cell volume yield and enhanced acidification activity in dairy cultures. This superior activity translates to improved performance in finished products, offering supplement brand owners potential advantages in formulation stability and efficacy. For product development, these new solutions facilitate optimisation and innovation, maintaining robust culture performance while increasing overall fermentation efficiency or supporting the creation of novel applications.
Gayathri Venkat, senior innovation manager at Sensient BioNutrients, emphasised that the goal was to create a fermentation ingredient specifically tailored to the precise needs of dairy culture manufacturers, rather than a generic yeast extract. Bhakti Pande, General Manager of Sensient BioNutrients, further noted that the Amberferm Grow products are designed to help customers 'do more with less,' providing a powerful solution amid strong consumer demand for dairy-derived products. These technologies are currently available in both North America and Europe, positioning them as an immediate opportunity for regional ingredient suppliers.
What this means for United Kingdom
UK supplement manufacturers reliant on fermented dairy cultures, such as probiotics or postbiotics, face potential cost reductions and improved supply stability. Enhanced yields from European suppliers, where the technology is available, could lower ingredient procurement costs by 5-15% and shorten lead times. Brand owners can leverage improved culture activity for novel product formulations, potentially securing competitive advantages in the functional food and gut health categories. Regulatory teams should monitor any specific labelling guidance from the FSA concerning fermentation enhancers, though initial indications suggest no direct impact on finished product claims. This innovation supports UK government objectives for supply chain resilience.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.